TriMed Clavicle Fixation System

K230805 · TriMed, Inc. · HRS · Sep 1, 2023 · Orthopedic

Device Facts

• Record ID: K230805
• Device Name: TriMed Clavicle Fixation System
• Applicant: TriMed, Inc.
• Product Code: HRS · Orthopedic
• Decision Date: Sep 1, 2023
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 888.3030
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The TriMed Clavicle Fixation Plates and Screws are intended for use in fixation of fractures, malunions, non-unions, and osteotomies of the clavicle.

Device Story

TriMed Clavicle Fixation System consists of metallic bone plates and screws for surgical fixation of clavicle fractures, malunions, non-unions, and osteotomies. System updates include improved plate contouring for bone fit, adjusted lengths to reduce subcutaneous prominence, and reduced plate thickness. Compatible with 2.7mm/3.2mm locking and non-locking screws. Used by surgeons in clinical/OR settings to stabilize bone segments. Provides mechanical fixation to facilitate bone healing. Manufactured from implant-grade 316 stainless steel.

Clinical Evidence

No clinical data. Substantial equivalence determined via bench testing, including static and endurance 4-point bending (ASTM F382-17), torsional strength, driving torque, axial pullout strength (ASTM D543-17), and biocompatibility (cytotoxicity, sensitization, irritation per ISO 10993-1:2018).

Technological Characteristics

Material: Implant-grade 316 stainless steel. Components: Bone plates and 2.7mm/3.2mm locking/non-locking screws. Mechanical testing per ASTM F382-17 (4-point bending) and ASTM D543-17 (torsional/driving torque/pullout). Biocompatibility per ISO 10993-1:2018.

Indications for Use

Indicated for fixation of fractures, malunions, non-unions, and osteotomies of the clavicle.

Regulatory Classification

Identification

Single/multiple component metallic bone fixation appliances and accessories are devices intended to be implanted consisting of one or more metallic components and their metallic fasteners. The devices contain a plate, a nail/plate combination, or a blade/plate combination that are made of alloys, such as cobalt-chromium-molybdenum, stainless steel, and titanium, that are intended to be held in position with fasteners, such as screws and nails, or bolts, nuts, and washers. These devices are used for fixation of fractures of the proximal or distal end of long bones, such as intracapsular, intertrochanteric, intercervical, supracondylar, or condylar fractures of the femur; for fusion of a joint; or for surgical procedures that involve cutting a bone. The devices may be implanted or attached through the skin so that a pulling force (traction) may be applied to the skeletal system.

Predicate Devices

• TriMed Clavicle Fixation System (K112509)
• DePuy Synthes 2.7mm VA LCP Clavicle Plate System (K201321)

Submission Summary (Full Text)

{0}------------------------------------------------

September 1, 2023

Image /page/0/Picture/1 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which consists of the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG" in blue, and then the word "ADMINISTRATION" in a smaller font size below that.

TriMed, Inc. % David Anderson Principle Consultant Tech2Med. LLC 6450 Old Darby TRL NE Ada. Michigan 49301

Re: K230805

Trade/Device Name: TriMed Clavicle Fixation System Regulation Number: 21 CFR 888.3030 Regulation Name: Single/Multiple Component Metallic Bone Fixation Appliances And Accessories Regulatory Class: Class II Product Code: HRS, HWC Dated: June 5, 2023 Received: June 5, 2023

Dear David Anderson:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal

{1}------------------------------------------------

statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email ([e-mail]) or phone [phone] or 301-796-7100).

Sincerely,

Shumaya Ali-S

Shumaya Ali, MPH Assistant Director DHT6C: Division of Restorative, Repair and Trauma Devices OHT6: Office of Orthopedic Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

# Indications for Use

510(k) Number (if known)

#### K230805

Device Name TriMed Clavicle Fixation System

#### Indications for Use (Describe)

The TriMed Clavicle Fixation Plates and Screws are in fixation of fractures, malunions, non-unions, and osteotomies of the clavicle.

| Type of Use (Select one or both, as applicable) | |
|---------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------|
| <div> <span> Prescription Use (Part 21 CFR 801 Subpart D) </span> </div> | <div> <span> Over-The-Counter Use (21 CFR 801 Subpart C) </span> </div> |

|_ | Over-The-Counter Use (21 CFR 801 Subpart C)

#### CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

# *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff [e-mail]

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

Image /page/3/Picture/0 description: The image shows the TriMed logo. The logo consists of a blue umbrella-like symbol on the left, followed by the word "TriMed" in blue, with a horizontal blue line underneath. The logo is simple and clean, with a focus on the company name and a memorable symbol.

# K230805 510(K) SUMMARY

| (a)(1). Submitted By: | TriMed, Inc.<br>27533 Avenue Hopkins<br>Santa Clarita, CA 91355<br>United States of America |
|---------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Contact Person: | David Anderson<br>Principle Regulatory Consultant<br>Office – [phone]<br>Fax – [phone] |
| Date: | August 31, 2023 |
| (a)(2). Proprietary Name: | TriMed Clavicle Fixation System |
| Common Name(s): | Plate, Fixation, Bone<br>Screw, Fixation, Bone |
| Classification Name: | 21 CFR 888.3030 (Primary): Single/multiple component<br>metallic bone fixation appliances and accessories.<br>21 CFR 888.3040: Smooth or threaded metallic bone fixation<br>fastener |
| Regulatory Class: | II |
| Product Codes: | HRS (Primary), HWC |
| (a)(3). Predicate Device: | Primary Predicate Device<br>K112509 – TriMed Clavicle Fixation System, TriMed, Inc.<br>(USA)<br>Additional Predicate Device<br>K201321 – DePuy Synthes 2.7mm VA LCP Clavicle Plate<br>System (CHE) |

# (a)(4). Device Description

The TriMed Clavicle Fixation System is a multi-indication plate and screw fixation system which provides surgical options for fractures, malunions, non-unions and osteotomies of the Clavicle.

TriMed Clavicle Plates have been updated for better plate contour fit to bone, updated lengths (so there is less subcutaneous plate prominence for the patient), and reduced plate thickness. TriMed Clavicle Plates are compatible with 2.7mm / 3.2mm locking and non-locking screws.

All TriMed plates and screws are manufactured from implant grade 316 stainless steel.

{4}------------------------------------------------

Image /page/4/Picture/0 description: The image shows the logo for TriMed. The logo consists of a blue symbol that looks like three interconnected arches, followed by the text "TriMed" in blue. A blue line is underneath the text.

### (a)(5). Indications for Use

The TriMed Clavicle Fixation Plates and Screws are intended for use in fixation of fractures, malunions, non-unions, and osteotomies of the clavicle.

### (a)(6). Technological Characteristics

The subject TriMed Clavicle Fixation System devices are similar to the predicate devices in material, size, packaging, sterility, and has similar indications for use. The TriMed Subject devices have been updated for better plate contour fit to bone, updated lengths (so there is less subcutaneous plate prominence for the patient), and reduced plate thickness as compared to predicate devices (K112509). Plate thickness and length ranges are comparable to predicate devices (K201321).

# (b)(1). Substantial Equivalence: - Non-Clinical Evidence Performance Data

TriMed Clavicle Fixation System Implants were evaluated for following:

- Static and endurance 4-point bending per ASTM F382-17. ●
- Cytotoxicity, Sensitization and Irritation testing in accordance with ISO 10993-1:2018
- All system screws were tested per FDA Guidance FDA-2019-D-1652 (ASTM D543-17) for: ●
- Torsional Strength O
- Driving Torque o
- Axial Pullout Strength Calculation O

# (b)(2). Substantial Equivalence: - Clinical Evidence

Clinical testing was not necessary for the determination of substantial equivalence.

#### (b)(3). Substantial Equivalence - Conclusions

TriMed Clavicle Fixation System devices are substantially equivalent to the predicate devices in which basic design features, intended uses, indications for use, manufacturing, packaging, and labeling are the same. Any differences between the proposed device and the predicate device are considered minor and do not raise different questions concerning safety or effectiveness.

Mechanical testing data and engineering analyses show the subject devices are substantially equivalent to that of the predicate devices for the desired indications.

Based on the indications for use, technological characteristics, and the summary of data submitted, TriMed Inc. has determined that the proposed devices are substantially equivalent to the currently marketed predicate device.